If you need more lookups,
subscriptions start at $34 USD/month.
John Gabrielson Location
Longmont, CO, US
John Gabrielson Work
President of Coriolis US @ (October 2025 - Present)
Senior Consultant @ (September 2025 - Present)
President and Founder @ Mederix Consulting (August 2025 - Present)
Senior Vice President, Pharmaceutical Development @ (July 2024 - August 2025)
Senior Vice President, Biosimilars and Head of Similis Bio @ (April 2022 - July 2024)
Senior Vice President, Analytical and Formulation Sciences @ (April 2021 - April 2022)
Vice President, Analytical Sciences @ (January 2018 - April 2021)
President @ Elion Labs (July 2015 - January 2018)
Principal Scientist @ (March 2012 - July 2015)
Senior Scientist @ (March 2009 - March 2012)
Scientist @ (October 2006 - March 2009)
John Gabrielson Education
University of Colorado Boulder
Doctor of Philosophy (PhD) (Chemical Engineering)
2003-2007
Colorado School of Mines
Bachelor of Science (BSc) (Chemical Engineering)
1999-2003
John Gabrielson Skills
Assay Development
Biopharmaceuticals
Biosimilars
Biotechnology
Business Strategy
CMC development
Chromatography
GMP
Good Manufacturing Practice (GMP)
HPLC
Protein Chemistry
Strategy
Technology Transfer
Chemical Engineering
Cell Culture
Molecular Biology
Business Development
Development
Management
Philosophy
Chemistry
Leadership
Strategic Planning
Quality Control
John Gabrielson Summary
John Gabrielson, based in Longmont, CO, US, is currently a President of Coriolis US at Coriolis Pharma. John Gabrielson brings experience from previous roles at Pharmefex Consulting, Mederix Consulting, Sidewinder Therapeutics, Inc and JSR Life Sciences. John Gabrielson holds a 2003 - 2007 Doctor of Philosophy (PhD) in Chemical Engineering @ University of Colorado Boulder. With a robust skill set that includes Assay Development, Biopharmaceuticals, Biosimilars, Biotechnology, Business Strategy and more. John Gabrielson has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different John Gabrielson?
Find contact details for 700 million professionals.